Theradiag launches €5.3 million rights issue
PARIS, FRANCE: Theradiag, a company specializing in in vitro diagnostics and Theranostics, announced the launch of a rights issue for a target amount of €5.3 million issuing 4.37 million shares at a price of €1.22 per share at a ratio…